Stephen R. Mattarollo

4.1k total citations
48 papers, 2.2k citations indexed

About

Stephen R. Mattarollo is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Stephen R. Mattarollo has authored 48 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 22 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Stephen R. Mattarollo's work include Immune Cell Function and Interaction (29 papers), Immunotherapy and Immune Responses (26 papers) and CAR-T cell therapy research (16 papers). Stephen R. Mattarollo is often cited by papers focused on Immune Cell Function and Interaction (29 papers), Immunotherapy and Immune Responses (26 papers) and CAR-T cell therapy research (16 papers). Stephen R. Mattarollo collaborates with scholars based in Australia, United States and Japan. Stephen R. Mattarollo's co-authors include Ian H. Frazer, Graham R. Leggatt, Mark J. Smyth, Andrew J. Nicol, Mie Nieda, Helene Duret, Yuting Ma, Laurence Zitvogel, Hirotake Tokuyama and Sherene Loi and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Stephen R. Mattarollo

48 papers receiving 2.1k citations

Peers

Stephen R. Mattarollo
Tomasz Ahrends United States
Mar Cabeza-Cabrerizo United Kingdom
Alice E. Denton United Kingdom
Kim Vrijland Netherlands
Peter Mottram United States
Tomasz Ahrends United States
Stephen R. Mattarollo
Citations per year, relative to Stephen R. Mattarollo Stephen R. Mattarollo (= 1×) peers Tomasz Ahrends

Countries citing papers authored by Stephen R. Mattarollo

Since Specialization
Citations

This map shows the geographic impact of Stephen R. Mattarollo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen R. Mattarollo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen R. Mattarollo more than expected).

Fields of papers citing papers by Stephen R. Mattarollo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen R. Mattarollo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen R. Mattarollo. The network helps show where Stephen R. Mattarollo may publish in the future.

Co-authorship network of co-authors of Stephen R. Mattarollo

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen R. Mattarollo. A scholar is included among the top collaborators of Stephen R. Mattarollo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen R. Mattarollo. Stephen R. Mattarollo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrer‐Font, Laura, R. J. Anderson, Benjamin J. Compton, et al.. (2022). Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect. OncoImmunology. 11(1). 2081009–2081009. 6 indexed citations
2.
Kobayashi, T, Pui Yeng Lam, Hui Jiang, et al.. (2020). Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment. Blood. 136(26). 3004–3017. 113 indexed citations
3.
Lam, Pui Yeng, T Kobayashi, Megan S. F. Soon, et al.. (2019). NKT Cell–Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion. Cancer Immunology Research. 7(6). 952–962. 11 indexed citations
4.
Tuong, Zewen Kelvin, T Kobayashi, Megan S. F. Soon, et al.. (2017). B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity. OncoImmunology. 7(2). e1393599–e1393599. 15 indexed citations
5.
Lam, Pui Yeng, Michael Nissen, & Stephen R. Mattarollo. (2017). Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies. Frontiers in Immunology. 8. 1355–1355. 23 indexed citations
6.
Kuo, Po‐Lin, Zewen Kelvin Tuong, Stephen R. Mattarollo, & Ian H. Frazer. (2016). Pre-malignant immune suppressive environment is dependent on HPV16E7-Rb interaction induced epithelium hyperplasia. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
7.
Kobayashi, T, et al.. (2015). NKT cell-targeted vaccination plus anti-4–1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma. OncoImmunology. 4(3). e990793–e990793. 31 indexed citations
8.
Tran, Le Son, Deepak Mittal, Stephen R. Mattarollo, & Ian H. Frazer. (2015). Interleukin-17A Promotes Arginase-1 Production and 2,4-Dinitrochlorobenzene-Induced Acute Hyperinflammation in Human Papillomavirus E7 Oncoprotein-Expressing Skin. Journal of Innate Immunity. 7(4). 392–404. 11 indexed citations
9.
Gosmann, Christina, Ian H. Frazer, Stephen R. Mattarollo, & Antje Blumenthal. (2014). IL-18, but Not IL-12, Induces Production of IFN-γ in the Immunosuppressive Environment of HPV16 E7 Transgenic Hyperplastic Skin. Journal of Investigative Dermatology. 134(10). 2562–2569. 31 indexed citations
10.
Tran, Le Son, Anne‐Sophie Bergot, Stephen R. Mattarollo, Deepak Mittal, & Ian H. Frazer. (2014). Human Papillomavirus E7 Oncoprotein Transgenic Skin Develops an Enhanced Inflammatory Response to 2,4-Dinitrochlorobenzene by an Arginase-1-Dependent Mechanism. Journal of Investigative Dermatology. 134(9). 2438–2446. 10 indexed citations
11.
West, Alison C., Stephen R. Mattarollo, Jake Shortt, et al.. (2013). An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors. Cancer Research. 73(24). 7265–7276. 117 indexed citations
12.
Ma, Yuting, Stephen R. Mattarollo, Sandy Adjemian, et al.. (2013). CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy. Cancer Research. 74(2). 436–445. 117 indexed citations
13.
Yong, Michelle C.R., Sharmal Narayan, Stephen R. Mattarollo, et al.. (2013). Expression of a Single, Viral Oncoprotein in Skin Epithelium Is Sufficient to Recruit Lymphocytes. PLoS ONE. 8(2). e57798–e57798. 24 indexed citations
14.
Mattarollo, Stephen R. & Mark J. Smyth. (2012). NKT cell adjuvants in therapeutic vaccines against hematological cancers. OncoImmunology. 2(1). e22615–e22615. 15 indexed citations
15.
Mattarollo, Stephen R., Sherene Loi, Helene Duret, et al.. (2011). Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors. Cancer Research. 71(14). 4809–4820. 256 indexed citations
16.
Mattarollo, Stephen R., et al.. (2010). Secretion of IFN-γ but Not IL-17 by CD1d-Restricted NKT Cells Enhances Rejection of Skin Grafts Expressing Epithelial Cell-Derived Antigen. The Journal of Immunology. 184(10). 5663–5669. 28 indexed citations
17.
Mattarollo, Stephen R., et al.. (2009). Invariant NKT Cells in Hyperplastic Skin Induce a Local Immune Suppressive Environment by IFN-γ Production. The Journal of Immunology. 184(3). 1242–1250. 54 indexed citations
18.
Tokuyama, Hirotake, Stephen R. Mattarollo, Qiao Wang, et al.. (2008). Vγ9Vδ2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs—Rituximab and trastuzumab. International Journal of Cancer. 122(11). 2526–2534. 128 indexed citations
19.
Mattarollo, Stephen R., Tony Kenna, Mie Nieda, & Andrew J. Nicol. (2006). Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to Vα24+ NKT cell-mediated cytotoxicity. Faculty of Health; Institute of Health and Biomedical Innovation. 1 indexed citations
20.
Mattarollo, Stephen R., Tony Kenna, Mie Nieda, & Andrew J. Nicol. (2006). Chemotherapy pretreatment sensitizes solid tumor‐derived cell lines to Vα24+ NKT cell‐mediated cytotoxicity. International Journal of Cancer. 119(7). 1630–1637. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026